One Pager as on February 28, 2023
Agile quality portfolio from India's Big 100 Companies* | |
Exposure to the more stable half of the market | |
High conviction bottom up stock picking with a focus on alpha generation | |
*In terms of Full Market Capitalisation. |
Data as on February 28, 2023
Sector | MMLCF | Nifty 100 Index TRI |
Financial Services | 35.07% | 35.00% |
Information Technology | 15.83% | 13.50% |
Oil Gas & Consumable Fuels | 8.86% | 11.54% |
Fast Moving Consumer Goods | 8.71% | 9.79% |
Automobile And Auto Components | 6.89% | 5.22% |
Data as on February 28, 2023
Security | % to Net Assets |
HDFC Bank Limited | 9.53% |
ICICI Bank Limited | 9.17% |
Reliance Industries Limited | 7.34% |
Infosys Limited | 7.04% |
Tata Consultancy Services Limited | 5.92% |
Larsen & Toubro Limited | 4.18% |
State Bank of India | 4.17% |
Axis Bank Limited | 3.97% |
Maruti Suzuki India Limited | 3.86% |
Hindustan Unilever Limited | 2.98% |
Total | 58.15% |
Fresh Additions | Complete Exits |
Security | Security |
GAIL (India) Limited | Ambuja Cements Limited |
Housing Development Finance Corporation Limited | APL Apollo Tubes Limited |
UltraTech Cement Limited | HCL Technologies Limited |
Life Insurance Corporation Of India | |
Piramal Pharma Limited | |
Siemens Limited |
Note:
The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult their financial, tax and other advisors before taking any investment decision(s). Data as on February 28, 2023
Turnover Ratio (Last 1 year) | 1.11 |
Standard Deviation | 20.29% |
Beta1 | 0.88 |
Sharpe Ratio# | 0.46 |
Jenson's Alpha2 | -0.0377 |
#Risk-free rate assumed to be 6.70% (MIBOR as on 28-02-23) - Source: www.mmda.org
1. Beta is calculated on the basis of average monthly rolling returns as of last day of the month since inception till February 28, 2023 and annualized. 2. Calculated for the period since inception till February 28, 2023. | Data Source: ICRA Analytics, Bloomberg | Data as on February 28, 2023
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 15-Mar-2019.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Abhinav Khandelwal is managing this scheme since March 1, 2022. Ms. Fatema Pacha is managing this scheme since December 21, 2020. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 15-Mar-2019.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate. $Dedicated Fund Manager for Overseas Investments.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above are of Growth Option under Regular Plan Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Abhinav Khandelwal manages 6 schemes and
Ms. Fatema Pacha manages 9 schemes of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Performance as on February 28, 2023.
This product is suitable for investors who are seeking*:
• Long term capital appreciation;
• Investment predominantly in equity and equity related securities including derivatives of large cap companies.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.